# Stepan Co: overview

SCL · NYSE · CIK 94049 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/scl.md) · [Financials](/companies/scl/financials.md) · [Filings](/companies/scl/filings.md) · [Insiders](/companies/scl/insiders.md)

Latest reported revenue: [$684.1m](/filings/0001193125-26-334428.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-334428).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [547](/filings/0001193125-25-266074.md) | [526 d](/filings/0001193125-26-074976.md) | [593](/filings/0001193125-26-208061.md) | [595](/filings/0001193125-26-334428.md) | [590](/filings/0001193125-25-266074.md) | [554 d](/filings/0001193125-26-074976.md) | [605](/filings/0001193125-26-208061.md) | [684](/filings/0001193125-26-334428.md) |
| Gross margin | % | [13.8%](/filings/0001193125-25-266074.md) | [10.8% d](/filings/0001193125-26-074976.md) | [12.7%](/filings/0001193125-26-208061.md) | [12.1%](/filings/0001193125-26-334428.md) | [12.0%](/filings/0001193125-25-266074.md) | [9.3% d](/filings/0001193125-26-074976.md) | [10.7%](/filings/0001193125-26-208061.md) | [14.6%](/filings/0001193125-26-334428.md) |
| Operating margin | % | [4.4%](/filings/0001193125-25-266074.md) | [1.5% d](/filings/0001193125-26-074976.md) | [4.8%](/filings/0001193125-26-208061.md) | [3.0%](/filings/0001193125-26-334428.md) | [3.7%](/filings/0001193125-25-266074.md) | [1.9% d](/filings/0001193125-26-074976.md) | [(8.2%)](/filings/0001193125-26-208061.md) | [5.4%](/filings/0001193125-26-334428.md) |
| Net margin | % | [4.3%](/filings/0001193125-25-266074.md) | [0.6% d](/filings/0001193125-26-074976.md) | [3.3%](/filings/0001193125-26-208061.md) | [1.9%](/filings/0001193125-26-334428.md) | [1.8%](/filings/0001193125-25-266074.md) | [0.9% d](/filings/0001193125-26-074976.md) | [(6.8%)](/filings/0001193125-26-208061.md) | [3.3%](/filings/0001193125-26-334428.md) |
| Diluted EPS | $ per share | [1.03](/filings/0001193125-25-266074.md) | not reported | [0.86](/filings/0001193125-26-208061.md) | [0.50](/filings/0001193125-26-334428.md) | [0.47](/filings/0001193125-25-266074.md) | not reported | [(1.81)](/filings/0001193125-26-208061.md) | [1.00](/filings/0001193125-26-334428.md) |
| Free cash flow | $m | [(4.0) d](/filings/0001193125-25-266074.md) | [32.1 d](/filings/0001193125-26-074976.md) | [(25.8)](/filings/0001193125-26-208061.md) | [(14.4) d](/filings/0001193125-26-334428.md) | [40.2 d](/filings/0001193125-25-266074.md) | [25.4 d](/filings/0001193125-26-074976.md) | [(14.0)](/filings/0001193125-26-208061.md) | [(15.0) d](/filings/0001193125-26-334428.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,346](/filings/0000950170-24-022778.md) | [2,773](/filings/0000950170-25-029079.md) | [2,326](/filings/0001193125-26-074976.md) | [2,180](/filings/0001193125-26-074976.md) | [2,332](/filings/0001193125-26-074976.md) |
| Gross margin | % | [16.9%](/filings/0000950170-24-022778.md) | [15.4%](/filings/0000950170-25-029079.md) | [11.9%](/filings/0001193125-26-074976.md) | [12.5%](/filings/0001193125-26-074976.md) | [11.6%](/filings/0001193125-26-074976.md) |
| Operating margin | % | [7.3%](/filings/0000950170-24-022778.md) | [7.5%](/filings/0000950170-25-029079.md) | [2.5%](/filings/0001193125-26-074976.md) | [3.2%](/filings/0001193125-26-074976.md) | [3.4%](/filings/0001193125-26-074976.md) |
| Net margin | % | [5.9%](/filings/0000950170-24-022778.md) | [5.3%](/filings/0000950170-25-029079.md) | [1.7%](/filings/0001193125-26-074976.md) | [2.3%](/filings/0001193125-26-074976.md) | [2.0%](/filings/0001193125-26-074976.md) |
| Diluted EPS | $ per share | [5.92](/filings/0000950170-24-022778.md) | [6.38](/filings/0000950170-25-029079.md) | [1.75](/filings/0001193125-26-074976.md) | [2.20](/filings/0001193125-26-074976.md) | [2.05](/filings/0001193125-26-074976.md) |
| Free cash flow | $m | [(122)](/filings/0000950170-24-022778.md) | [(141)](/filings/0000950170-25-029079.md) | [(85.5)](/filings/0001193125-26-074976.md) | [39.3](/filings/0001193125-26-074976.md) | [25.4](/filings/0001193125-26-074976.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/scl/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $192.7m | 3,458,328 |  | Added +147,288 |
| [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $88.6m | 1,589,877 |  | Reduced −188 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $77.0m | 1,381,590 |  | Added +22,737 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $62.7m | 1,125,025 |  | Added +7,995 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $52.9m | 949,949 |  | Added +7,958 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $52.9m | 948,532 |  | Added +216,411 |
| [DEPRINCE RACE & ZOLLO INC](/funds/1008894.md) | 2026-06-30 | $52.2m | 936,608 |  | Reduced −10,844 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $49.5m | 888,716 |  | Reduced −13,948 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $31.5m | 565,294 |  | Added +35,734 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $24.2m | 433,582 |  | Added +40,313 |

## Recent filings

[All 1,953 filings](/companies/scl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 07:00 ET | [8-K](/filings/0001193125-26-435067.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-435067 |
| 2026-09-28 | 21:47 ET | [8-K](/filings/0001193125-26-403127.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-403127 |
| 2026-08-05 | 12:37 ET | [10-Q](/filings/0001193125-26-334428.md) | Quarterly report, period 2026-06-30 | 0001193125-26-334428 |
| 2026-07-29 | 07:00 ET | [8-K](/filings/0001193125-26-322116.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-322116 |
| 2026-05-06 | 11:40 ET | [10-Q](/filings/0001193125-26-208061.md) | Quarterly report, period 2026-03-31 | 0001193125-26-208061 |
| 2026-04-30 | 08:00 ET | [8-K](/filings/0001193125-26-194098.md) | 5.07 Shareholder vote results | 0001193125-26-194098 |
| 2026-04-28 | 07:00 ET | [8-K](/filings/0001193125-26-183483.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-183483 |
| 2026-03-25 | 06:35 ET | [DEF 14A](/filings/0001193125-26-122725.md) | Proxy statement, period 2026-04-28 | 0001193125-26-122725 |
| 2026-02-26 | 12:44 ET | [10-K](/filings/0001193125-26-074976.md) | Annual report, period 2025-12-31 | 0001193125-26-074976 |
| 2026-02-23 | 07:05 ET | [8-K](/filings/0001193125-26-062405.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-062405 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-074976.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/6e7daaa3-bd07-4951-8c04-615bd43dbc58)

## About the filer

- CIK: 94049
- Tickers: SCL
- Exchange: NYSE
- SIC code: 2840 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 07:01 ET. No prices; not investment advice.